Document is current
Any future updates will be listed below
-
Authors
Gillings, Nic
Hjelstuen, Olaug
Behe, Martin
Decristoforo, Clemens
Elsinga, Philip H.
Ferrari, Valentina
Kiss, Oliver C. https://orcid.org/0000-0001-7431-0026
Kolenc, Petra
Koziorowski, Jacek
Laverman, Peter
Mindt, Thomas L.
Ocak, Meltem
Patt, Marianne
Todde, Sergio
Walte, Almut
-
Funding
Funding for this research was provided by:
Helmholtz-Zentrum Dresden - Rossendorf e. V.
- License Information
-
More Information
Article History
Received: 18 January 2022
Accepted: 17 February 2022
First Online: 7 April 2022
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: The authors declare no competing interests.
: This guideline summarises the views of the EANM Radiopharmacy Committee. It reflects recommendations for which the EANM cannot be held responsible. The recommendations should be taken into the context of good practice of nuclear medicine and do not substitute for national and international legal or regulatory provisions Tables and .
